|
| CAP synoptic form item: Primary Tumor (pT). |
| May contain organization-specific values: Yes |
| Category Entries: |
| pTX: Cannot be determined |
| pTX: Cannot be assessed, or tumor proven by presence of malignant cells in sputum or |
| pTX: Cannot be assessed |
| pT0: No evidence of primary tumor |
| pTis: Carcinoma in situ |
| pTis (DCIS): Ductal carcinoma in situ |
| pTis (LCIS): Lobular carcinoma in situ |
| pTis (Paget): Paget disease of the nipple NOT associated with invasive carcinoma and |
| pTis: Carcinoma in situ, intraepithelial (no invasion) |
| pTis: Carcinoma in situ, invasion of lamina propria |
| pTis: High-grade dysplasia / carcinoma in situ |
| pTis: Tubal intraepithelial carcinoma (limited to tubal mucosa) |
| pTis: Melanoma in situ (i.e., not an invasive tumor: anatomic level I) |
| Encapsulated |
| Extracapsular extension without adjacent organ involvement |
| Extension into adjacent organs |
| Extension into spinal canal |
| pTa: Papillary noninvasive carcinoma |
| pTa: Noninvasive papillary carcinoma |
| pTis: Intratubular germ cell neoplasia only (carcinoma in situ) |
| pTis: Flat carcinoma in situ |
| pTis: Carcinoma in situ: flat tumor |
| Iris |
| Ciliary Body and Choroid |
| pT1: Tumor 5 cm or less in greatest dimension, no extra-adrenal invasion |
| pT1: Tumor limited to ampulla of Vater or sphincter of Oddi |
| pT1: Tumor 2 cm or less in greatest dimension |
| pT1: Tumor invades submucosa |
| pT1: Tumor confined to the bile duct histologically |
| pT1: Solitary tumor without vascular invasion |
| pT1: Tmr confined to bile duct, w/ extension up to muscle layer or fibrous tissue |
| pT1: Tumor 8 cm or less in greatest dimension |
| pT1mi: Tumor <= 1 mm in greatest dimension (microinvasion) |
| pT1a: Tumor > 1 mm but <= 5 mm in greatest dimension |
| pT1b: Tumor > 5 mm but <= 10 mm in greatest dimension |
| pT1c: Tumor > 10 mm but <= 20 mm in greatest dimension |
| pT1a (IA): Tumor limited to endometrium or invades less than one-half of myometrium |
| pT1b (IB): Tumor invades greater than or equal to one-half of the myometrium |
| pT1: Tumor invades lamina propria, muscularis mucosae, or submucosa |
| pT1a: Tumor invades lamina propria or muscularis mucosae |
| pT1a: Tumor invades lamina propria |
| pT1 (I): Tumor limited to fallopian tube(s) |
| pT1a (IA): Tumor limited to 1 tube without penetrating serosal surface; no ascites |
| pT1b (IB): Tumor limited to both tubes w/o penetrating serosal surface; no ascites |
| pT1c (IC): Tmr limited to 1 or both tube(s) w/ extension into or through tubal serosa |
| pT1b: Tumor invades submucosa |
| pT1b: Tumor invades muscle layer |
| pT1: Tumor 7 cm or less in greatest dimension, limited to the kidney |
| pT1a: Tumor 4 cm or less in greatest dimension, limited to the kidney |
| pT1b: Tumor > 4cm but not more than 7cm in greatest dimension, limited to kidney |
| pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung or visceral pleura |
| pT1b: Tumor greater than 2 cm, but 3 cm or less in greatest dimension, surrounded by |
| pT1: Tumor <=2cm in greatest dimension (without extraparenchymal extension) (Note I) |
| pT1a: Tumor limited to ipsilateral parietal pleura with or without mediastinal or |
| pT1b: Tumor involves ipsilateral parietal pleura with or without mediastinal or |
| pT1a: Melanoma 1.0 mm or less in thickness, no ulceration, <1 mitoses / mm*mm |
| pT1b: Melanoma 1.0 mm or less in thickness with ulceration and/or 1+ mitoses/mm*mm |
| pT1a (IA): Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. N |
| pT1b (IB): Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface |
| pT1c (IC): Tumor limited to one or both ovaries with any of the following: capsule |
| pT1: Tumor limited to the pancreas, 2 cm or less in greatest dimension |
| pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimen |
| pT1: Tumor confined to nasopharynx, or tumor extends to oropharynx and / or nasal |
| pT1: Tmr limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimen |
| pT1: Tumor invades subepithelial connective tissue (lamina propria) |
| pT1: Tumor confined to the eye with no optic nerve or choroidal invasion |
| pT1a: Tumor 5 cm or less in greatest dimension, superficial tumor |
| pT1b: Tumor 5 cm or less in greatest dimension, deep tumor |
| pT1: Tumor 2 cm or less in greatest dimension with less than two high risk features |
| pT1: Tumor limited to the testis and epididymis without vascular / lymphatic invasion |
| pT1: Tumor size 2 cm or less, limited to thyroid |
| pT1a: Tumor 1 cm or less in greatest dimension limited to the thyroid |
| pT1b: Tmr more than 1 cm but not more than 2cm in greatest dimen., limited to thyroid |
| pT1 (I): Tumor confined to uterus |
| pT1a (IA): Invasive carcinoma diagnosed by microscopy only. All macroscopically |
| pT1a1 (IA1): Stromal invasion 3.0mm or less in depth, horizontal spread 7.0mm or less |
| pT1a2 (IA2): Stromal invasion more than 3.0 mm but not more than 5.0 mm in depth |
| pT1b (IB): Clinically visible lesion confined to cervix/microscopic lesion > T1a2/IA2 |
| pT1b1 (IB1): Clinically visible lesion 4.0 cm or less in greatest dimension |
| pT1b2 (IB2): Clinically visible lesion more than 4.0 cm in greatest dimension |
| pT1 (I): Tumor confined to vaginal wall |
| pT1a (FIGO IA): Lesions 2 cm or less in size, confined to the vulva or perineum |
| pT1b (FIGO IB): Lesions more than 2 cm in size or any size with stromal invasion more |
| pT2: Tumor greater than 5 cm, no extra-adrenal invasion |
| pT2: Tumor invades duodenal wall |
| pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension |
| pT2: Tumor invades muscularis propria |
| pT2: Tumor invades beyond the wall of the bile duct |
| pT2a: Solitary tumor with vascular invasion |
| pT2b: Multiple tumors, with or without vascular invasion |
| pT2a: Tumor invades beyond the wall of the bile duct to surrounding adipose tissue |
| pT2b: Tumor invades adjacent hepatic parenchyma |
| pT2: Tumor more than 8 cm in greatest dimension |
| pT2: Tumor > 20 mm but <= 50 mm in greatest dimension |
| pT2 (II): Tumor invades stromal connective tissue of the cervix, but does not extend |
| pT2 (II): Tumor involves 1 or both tube(s) with pelvic extension |
| pT2a (IIA): Extension and / or metastasis to the uterus and / or ovaries |
| pT2b (IIB): Extension to other pelvic structures |
| pT2c (IIC): Pelvic extension (T2a,T2b/IIA or IIB) w/ malignant cells in ascites |
| pT2: Tmr invades perimuscular connective tissue; no extension beyond serosa/in liver |
| pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm |
| pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney |
| pT2a: Tumor more than 7 cm but >= 10 cm in greatest dimension, limited to kidney |
| pT2b: Tumor more than 10 cm, limited to the kidney |
| pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension |
| pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest dimension surrounded by l |
| pT2b: Tumor greater than 5 cm, but 7 cm or less in greatest dimension |
| pT2: Tumor >2cm but <=4cm in greatest dimension (without extraparenchymal extension) |
| pT2: Tumor involves each of the ipsilateral pleural surfaces (parietal, mediastinal, |
| pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration |
| pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration |
| pT2a (IIA): Extension and / or implants on uterus and / or tube(s). No malignant cell |
| pT2b (IIB): Extension to other pelvic tissues. No malignant cells in ascites or |
| pT2c (IIC): Pelvic extension and/or implants (T2a or T2b / IIa or IIb) with malignant |
| pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension |
| pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than |
| pT2: Tumor with parapharyngeal extension |
| pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or |
| pT2: Organ confined |
| pT2a: Unilateral, involving one-half of 1 side or less |
| pT2b: Unilateral, involving more than one-half of 1 side but not both sides |
| pT2c: Bilateral disease |
| pT2a: Tmr invades optic nerve head no extend past lamina or focal choroidal invasion |
| pT2b: Tmr invades optic nerve head no extend past lamina and focal choroidal invasion |
| pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor |
| pT2b: Tumor more than 5 cm in greatest dimension, deep tumor |
| pT2: Tumor greater than 2 cm in greatest dimension with or without one additional |
| pT2: Tumor limited to the testis and epididymis with vascular / lymphatic invasion |
| pT2: Tumor more than 2 cm, but not more than 4 cm, limited to thyroid |
| pT2 (II): Tumor extends outside of the uterus but is limited to genital structures |
| pT2a: Tumor invades superficial muscularis propria (inner half) |
| pT2b: Tumor invades deep muscularis propria (outer half) |
| pT2a (IIA): Tumor without parametrial invasion |
| pT2a1 (IIA1): Clinically visible lesion less than or equal to 4.0cm in greatest dimen |
| pT2a2 (IIA2): Clinically visible lesion greater than 4.0 cm in greatest dimension |
| pT2b (IIB): Tumor with parametrial invasion |
| pT2 (II): Tumor invades paravaginal tissues but not the pelvic wall |
| pT2 (FIGO II): Tumor of any size with extension to adjacent perineal structures |
| pT3: Tumor of any size with local invasion, but not invading adjacent organs |
| pT3: Tumor invades pancreas |
| pT3: Tumor more than 5 cm in greatest dimension |
| pT3: Tumor invades through the muscularis propria into the subserosa or mesoappendix |
| pT3: Tmr invades gallbladder,pancreas,duodenum,other adj. organs w/o involvement of |
| pT3: Tmr perforates visc. peritoneum/invol local extrahepatic struct. by direct invas |
| pT3: Tumor invades unilateral branches of the portal vein or hepatic artery |
| pT3: Discontinuous tumors in primary bone site (not including skip metastases) |
| pT3: Tumor > 50 mm in greatest dimension |
| pT3: Tumor invades through the muscularis propria into pericolorectal tissues |
| pT3a (IIIA): Tumor involves serosa and / or adnexa (direct extension or metastasis) |
| pT3b (IIIB): Vaginal involvement (direct extension/metastasis) or parametrial involve |
| pT3: Tumor invades adventitia |
| pT3/N1 (III): Tmr involves 1 or both tube(s) with peritoneal implants outside pelvis |
| pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis |
| pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2cm in greatest dimen |
| pT3c / NI (IIIC): Peritoneal metastasis beyond pelvis >2cm in greatest dimen |
| pT3: Tumor perforates serosa (visceral peritoneum) and/or directly invades the liver |
| pT3a: Multiple tumors more than 5 cm |
| pT3b: Single/multiple tmrs any size involving major branch of portal/hepatic veins |
| pT3: Tmr extends into major veins/perinephric tissues, not into ipsilateral adrenal |
| pT3a: Tumor grossly extends into the renal vein or its segmental (muscle containing) |
| pT3b: Tumor grossly extends into the vena cava below the diaphragm |
| pT3c: Tmr grossly extends into vena cava above diaphragm or invades wall of vena cava |
| pT3: Mucosal disease |
| pT3: Tumor more than 4 cm in greatest dimension |
| pT3: Tumor greater than 7 cm in greatest dimension; or Tumor of any size that |
| pT3: Tumor more than 4 cm and / or tumor (having extraparenchymal extension) (Note I) |
| pT3: Locally advanced but potentially resectable tumor that involves all of the |
| pT3a: Melanoma 2.01 to 4.0 mm in thickness, no ulceration |
| pT3b: Melanoma 2.01 to 4.0 mm in thickness, with ulceration |
| pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor) |
| pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2 cm in greatest dimen |
| pT3c and / or N1 (IIIC): Peritoneal metastasis beyond pelvis >2 cm in greatest dimen |
| pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or |
| pT3: Tmr >4 cm in greatest dimension/extension to lingual surface of epiglottis |
| pT3: Tumor invades bony structures of skull base and / or paranasal sinuses |
| pT3: Tumor measures more than 4 cm in greatest dimension or with fixation of hemilary |
| pT3a: Extraprostatic extension or microscopic invasion of bladder neck |
| pT3b: Seminal vesicle invasion |
| pT3: Tumor invades beyond muscularis into peripelvic fat or the renal parenchyma |
| pT3a: Tumor invades optic nerve past lamina cribrosa OR focal choroidal invasion |
| pT3b: Tumor invades optic nerve past lamina cribrosa AND focal choroidal invasion |
| pT3: Tumor invades through the muscularis propria into the subserosa or into the |
| pT3: Tumor with invasion of maxilla, mandible, orbit, or temporal bone |
| pT3: Tumor invades subserosal connective tissue, without involvement of |
| pT3: Tumor invades spermatic cord with or without vascular / lymphatic invasion |
| pT3: Tumor >4 cm limited to thyroid or any tumor with minimal extrathyroid extension |
| pT3: Tumor invades beyond muscularis propria into periureteric fat |
| pT3a: Microscopically |
| pT3b: Macroscopically (extravesicular mass) |
| pT3a (IIIA): Tumor involves lower third of vagina, but not pelvic wall |
| pT3b (IIIB): Tmr extend to pelvic wall and/or causes hydronephrosis/non-funct. kidney |
| pT3 (III): Tumor extends to pelvic wall |
| pT3 (FIGO IVA): Tumor of any size with extension to any of the following |
| pT4: Tumor of any size with invasion of adjacent organs |
| pT4: Tumor invades peripancreatic soft tissues or other adjacent organs or structures |
| pT4: Tmr of any size w/ invasion of adjacent organ(s) e.g. vagina, urethra, bladder |
| pT4: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor within |
| pT4: Tumor involves the celiac axis or the superior mesenteric artery |
| pT4: Tumor with periductal invasion |
| pT4: Tumor invades main portal vein or its branches bilaterally; or the common hepati |
| pT4 (IVA): Tumor invades bladder mucosa and/or bowel mucosa |
| pT4: Tumor invades adjacent structures |
| pT4: Tumor invades main portal vein or hepatic artery or invades 2+ extrahepatic |
| pT4: Tmr w/ direct invasion of adj. organs other than gallbladder |
| pT4: Tmr invades beyond Gerota’s fascia |
| pT4: Tumor of any size that invades any of the following: mediastinum, heart, great |
| pT4: Locally advanced technically unresectable tumor involving all of the ipsilateral |
| pT4: Tumor with intracranial extension and / or involvement of cranial nerves, |
| pT4: Invasion of rectum, levator muscles, and / or pelvic wall (Note J) |
| pT4: Tumor invades adjacent organs, or through the kidney into the perinephric fat |
| pT4a: Tmr invades optic nerve to resection line, no extra-ocular extension identified |
| pT4b: Tumor invades optic nerve to resection line, extra-ocular extension identified |
| pT4: Tumor with direct or perineural invasion of skull base or axial skeleton |
| pT4: Tmr involves visc. peritoneum (serosal surf.) or directly invades adj. structure |
| pT4: Tumor invades scrotum with or without vascular / lymphatic invasion |
| pT4: Tumor invades adjacent organs |
| pT4 (IVA): Tmr invades the mucosa of bladder/rectum and/or extends beyond true pelvis |
| pT4 (IVA): Tmr invades mucosa of bladder or rectum and/or extends beyond true pelvis |
| pT4a: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor withi |
| pT4a: Tumor penetrates the visceral peritoneum |
| pT4a: Extension to chest wall, not including only pectoralis muscle adherence / invas |
| pT4b: Ulceration/ipsilateral satellite nodules/edema of skin which dont meet criteria |
| pT4c: Both T4a and T4b |
| pT4d: Inflammatory carcinoma |
| pT4b: Tumor directly invades other organs or structures |
| pT4b: Tumor directly invades or is adherent to other organs or structures |
| pT4a: Resectable tumor invading pleura, pericardium, or diaphragm |
| pT4b: Unresectable tmr invading other adj. structures, such as aorta, vertebral body |
| Any T / Any N and M1 (IV): Distant metastasis including presence of malignant cells |
| Primary Tumor (pT): Supraglottis |
| Primary Tumor (pT): Glottis |
| Primary Tumor (pT): Subglottis |
| pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage, bone, |
| pT4b: Very advanced disease. Tumor involving brain, dura, skull base, |
| pT4a: Moderately advanced local disease. |
| pT4b: Very advanced local disease. |
| pT4a: Moderately advanced local disease. Tumor invades skin, mandible, ear canal, |
| pT4b: Very advanced local disease. Tumor invades skull base and / or pterygoid plates |
| pT4a: Melanoma greater than 4.0 mm in thickness, no ulceration |
| pT4b: Melanoma greater than 4.0 mm in thickness, with ulceration |
| Primary Tumor (pT): Maxillary Sinus |
| Primary Tumor (pT): Nasal Cavity and Ethmoid Sinus |
| pT4a: Moderately advanced local disease. Tumor invades larynx, deep / extrinsic |
| pT4b: Very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid |
| pT4a: Moderately advanced local disease. Tumor invades thyroid / cricoid cartilage, |
| pT4b: Very advanced local disease. Tumor invades prevertebral fascia, encases |
| pT4a: Tumor involves visceral peritoneum (serosal surface) |
| pT4b: Tumor directly invades adjacent structures |
| pT4a: Moderately advanced disease. Tumor of any size extending beyond the thyroid |
| pT4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid |
| pT4a: Intrathyroidal anaplastic carcinoma-surgically resectable |
| pT4b: Extrathyroidal anaplastic carcinoma-surgically unresectable |
| pT4a: Tumor invades prostatic stroma or uterus or vagina |
| pT4b: Tumor invades pelvic wall or abdominal wall |
| Not identified |
